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Psoriatic arthritis (PsA) is a debilitating immune-mediated inflammatory arthritis of unknown
pathogenesis commonly affecting patients with skin psoriasis. Here we use complementary
single-cell approaches to study leukocytes from PsA joints. Mass cytometry demonstrates a
3-fold expansion of memory CD8 T cells in the joints of PsA patients compared to peripheral
blood. Meanwhile, droplet-based and plate-based single-cell RNA sequencing of paired T cell
receptor alpha and beta chain sequences show pronounced CD8 T cell clonal expansions
within the joints. Transcriptome analyses find these expanded synovial CD8 T cells to express
cycling, activation, tissue-homing and tissue residency markers. T cell receptor sequence
comparison between patients identifies clonal convergence. Finally, chemokine receptor
CXCR3 is upregulated in the expanded synovial CD8 T cells, while two CXCR3 ligands,
CXCL9 and CXCL10, are elevated in PsA synovial fluid. Our data thus provide a quantitative
molecular insight into the cellular immune landscape of psoriatic arthritis.
https://doi.org/10.1038/s41467-020-18513-6 OPEN
1 Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7LD, UK. 2Wellcome Sanger Institute,
Hinxton CB10 1SA, UK. 3 Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. 4Musculoskeletal Unit,
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK. 5Wellcome Centre for Human Genetics, University of Oxford,
Oxford OX3 7BN, UK. 6UCB Pharma, 216 Bath road, Slough SL1 3WE, UK. 7 NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham
NHS Foundation Trust and University of Birmingham, Institute of Inflammation and Ageing, Birmingham, UK. 8 Infection, Inflammation and Rheumatology
Section, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK. 9 Idorsia Pharmaceuticals Ltd., Drug Discovery Immunology,
Hegenheimermattweg 91, 4123 Allschwill, Switzerland. 10 Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. 11 Department of
Paediatrics, University of Cambridge, Cambridge CB2 0SP, UK. 12These authors contributed equally: Paul Bowness, Sam Behjati, M. Hussein Al-Mossawi.
✉email: sb31@sanger.ac.uk; Hussein.al-mossawi@ndorms.ox.ac.uk
NATURE COMMUNICATIONS |         (2020) 11:4767 | https://doi.org/10.1038/s41467-020-18513-6 | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Up to one-third of patients suffering from psoriasis developthe debilitating immune-mediated inflammatory jointdisease, psoriatic arthritis (PsA)1. The pathogenesis of
PsA is complex, involving multiple inflammatory pathways, and
is thought to be driven by immune cells entering or proliferating
within the joint synovial lining tissue and/or fluid2. Genome-wide
association studies of both psoriasis and PsA support a patho-
genic role for CD8 T cells, showing significant associations with
MHC class I allotypes and with other genes involved in T-cell
function3. Furthermore, clonal expansions of CD8 cells have been
reported in the synovial fluid of patients with PsA using bulk T-
cell receptor beta-chain sequencing approaches4. Costello and
colleagues identified an average of 32 private T-cell receptor
(TCR) beta-chain clonal expansions unique to individual patients
and primarily confined to synovial fluid. While they found evi-
dence supporting antigen-driven selection, with differing nucleic
acid sequences encoding common amino acid sequences, they did
not see evidence of shared or public repertoires between different
patients, as previously described for HLA-B27-associated spon-
dyloarthritis5. Leucocytes are recruited to the synovium and
synovial fluid through chemokine gradients, with bulk synovial
fluid cell pellet RNA showing increased expression of the CXCR3
gene and synovial fluid showing increased expression of one of its
protein ligands CCL106. A subgroup of patients with PsA develop
a distinct pattern of arthritis affecting predominantly large joints
termed large-joint oligo PsA7. These patients often require ther-
apeutic knee-joint aspiration that provides an opportunity to
examine the synovial fluid exudate and tissue in PsA.
Here, we study the cellular landscape of PsA blood, synovial
fluid and synovial tissue at single-cell resolution, combining mass
cytometry with chromium 10× genomics (10×) droplet-
encapsulated single-cell mRNA sequencing and validation by
full-length transcript Smart-seq 2 (SS2) single-cell mRNA
sequencing. We use 5′ chromium technology to unravel the
alpha-/beta-paired chain clonal architecture of T cells in the
synovial fluid compared to peripheral blood and match this with
gene expression. We identify clonal expansions of CD8 T cells in
PsA synovial fluid, show that single alpha–beta T-cell sister clones
exist in multiple cell states and highlight pathways that mediate
their trafficking into the joint. These findings have implications
for our understanding of the pathogenesis of PsA and other HLA-
associated immune-mediated inflammatory diseases, as well as
suggesting potential therapeutic approaches.
Results
Cellular landscape of PsA. Freshly isolated peripheral blood and
synovial fluid were obtained from patients with large-joint oligo
PsA presenting for arthrocentesis, and immediately (0.5–4 h)
processed for mass cytometry (CyTOF) and single-cell RNA
sequencing (Fig. 1a, b). We used CyTOF to quantify leucocyte
populations from matched synovial fluid and blood obtained
from ten patients. Blood and synovial fluid samples were fixed
within 30 min of collection, stained with a 38-marker antibody
panel (Supplementary Table 2) and then acquired on a CyTOF
Helios instrument. After pre-processing (Supplementary Fig. 1a),
we used t-stochastic neighbour embedding (t-SNE) to derive cell
clusters (Fig. 1c), which were annotated by FlowSOM8 (Supple-
mentary Fig. 1b, c). These analyses identified significant expan-
sions of synovial memory CD8 (p= 0.0059, paired t test) and
memory CD4 (p= 0.025, paired t test) T cells (Fig. 1d, e) in all
patients compared to blood. Plasmacytoid (p= 0.032, paired t
test) and conventional dendritic cells (p= 0.013, paired t test)
were also expanded in synovial fluid. B cells and basophils were
depleted (p= 0.0059 for both, paired t test), and monocytes,
gamma–delta T, mucosal invariant T (MAIT)9 and NK cells were
unchanged (Fig. 1d). 3′ droplet-encapsulated single-cell mRNA
sequencing of PBMC and SFMC from three PsA patients, carried
out in parallel, confirmed the presence of these cell types and did
not identify any additional cellular populations (Supplementary
Fig. 2a–c, Supplementary Data 1a).
Sequencing of PsA blood, synovial fluid and tissue T cells.
Supported by the genetic association of PsA with polymorphisms
in T-cell-related genes10 and the significant expansions observed
in our CyTOF analysis (Fig. 1d), we specifically interrogated the
transcriptional profile of synovial fluid memory CD4 and CD8 T-
cell populations. For three patients, we used droplet-encapsulated
single-cell 5′ mRNA sequencing (chromium 10×), with Smart-seq
2 validation in four patients (applying both 10× and Smart-seq 2
technology in parallel on the same sorted cells for one donor). For
both approaches, synovial fluid and blood were processed in
parallel directly ex vivo within 4 h, with single-cell suspensions
enriched for CD4 and CD8 T cells by flow cytometry-activated
cell sorting (FACS, Supplementary Fig. 3a). In addition, we
analysed CD4 and CD8 T-cell populations identified within
CD45+ sorted cells from the cryopreserved PsA knee synovial
tissue biopsies of two further patients, also using 5′ chromium
10× technology (Supplementary Fig. 3b, c, Supplementary Fig. 4,
Supplementary Data 1b). After applying stringent quality-control
criteria (“Methods”), we performed a unified analysis of
41,202 single T-cell transcriptomes of equal patient origin from
the paired blood and synovial fluid samples, together with 251 T-
cell transcriptomes from the synovial tissue biopsies (clusters 2, 3
and 8 from Supplementary Fig. 4a also expressing CD3E tran-
scripts) using the Seurat 3 pipeline. We identified 16 clusters of
memory CD4 and CD8 T cells (Fig. 2a), annotated with key
marker genes in Fig. 2b (Supplementary Fig. 5, Supplementary
Data 1c and 2). Of note, one cluster (cluster 16), primarily
composed of synovial CD8 T cells, was distinguished by high
expression of the proliferation markers MKI67 and STMN111,
indicating active proliferation of CD8 T cells within inflamed
joints. We observed accurate alignment of peripheral blood and
synovial fluid T cells, with cells originating from both sample
types present in all clusters for all patients (Fig. 2c, d, Supple-
mentary Fig. 6). Synovial tissue T cells also mapped to the
majority of clusters identified, although synovial tissue CD8
T cells predominantly mapped to cluster 2 (HLA-DR-low CD8)
(Fig. 2e, Supplementary Data 2). Comparing gene expression
between synovial fluid and blood T cells, we observed increased
expression of activation and effector markers in synovial fluid in
the HLA-DR-low CD8, HLA-DR- high CD8 and ZNF683+ CD8
clusters (Fig. 2f–h, Supplementary Data 3a–c). In particular, we
observed significantly upregulated expression of the MHC-II
genes HLA-DRB1 and HLA-DRA in the synovial HLA-DR-high
CD8 cluster, and increased expression of the effector molecules
GZMA and GZMB in the synovial fluid ZNF683+ CD8 cluster.
Of note, the T-cell receptor alpha-chain gene TRAV27 was sig-
nificantly upregulated in the synovial fluid compartment of the
ZNF683+ CD8 cluster compared to peripheral blood, suggestive
of synovial clonal expansion within this cluster.
CD8 T-cell clonal expansion in PsA synovial fluid. We used T-
cell receptor VDJ sequencing to understand the clonal composi-
tion of PsA blood and paired synovial fluid (Fig. 3a, b), mapping
paired alpha-/beta-chain TCR sequences to gene expression for
the same cells. We first looked systematically for evidence of
clonal expansion of CD4 and CD8 T cells in the blood and
synovial fluid for each of the three donors using the 10× data set
(Fig. 3c–f). For every individual, we observed between 7 and 20
CD8 clones (and 1–4 CD4 clones) significantly enriched in the
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synovial fluid; we also observed a lesser number of clones enri-
ched in the peripheral blood (see “Methods”, Supplementary
Data 4 and 5). Overall, cells from synovial-enriched clones were
most likely to be part of the HLA-DR-high, CD8 cycling or
ZNF683+ CD8 clusters (odds ratios 12.6, 4.73 and 3.66; adjusted
p value 0, 8.7E−19 and 6.1E−64, respectively, two-sided Fisher’s
exact test with Bonferroni correction, Supplementary Data 7a,
Fig. 3c). Looking at individual clones, cells from the majority of
synovial fluid-enriched clones were present in multiple pheno-
typic clusters (Fig. 3g). This was also the case for clones enriched
in peripheral blood. However, the HLA-DR-high and cycling
clusters were more often overrepresented by synovial-enriched
clones, while HLA-DR-low and transitional cluster phenotypes
were more common in peripheral blood-enriched clones. A
smaller number of enriched clones represented cells from the
ZNF683+ and central memory clusters for both sample types
(Supplementary Fig. 7). In addition, we carried out VDJ receptor
sequencing of CD4 and CD8 cells from the synovial tissue. Due to
the small number of cells obtained by biopsy, the largest clone
observed came from one sample and mapped to four CD8 cells
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Fig. 1 Landscape of synovial leukocyte populations in psoriatic arthritis. a Overview of experimental design. b Cell numbers used in each of the
experimental techniques. c Representative map of CyTOF clusters derived from one PsA patient’s matched peripheral blood and synovial fluid cells using
t-SNE. d Boxplots showing cluster frequencies within blood and synovial fluid (SF) from ten independent experiments. All replication attempts were
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smallest value, 1.5× IQR from the 25th centile. The junctions of whisker and box (hinge) represent the 25th and 75th centiles, while median is indicated by
the central line. Outlier values are plotted individually beyond the whiskers. Two-sided paired t test with Bonferroni correction. n= 10 (*= p < 0.05, **=p <
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Fig. 2 Transcriptional landscape of CD4 and CD8 T cells in psoriatic arthritis. a UMAP of integrated PsA blood, synovial fluid and synovial tissue
memory CD4 and CD8 T cells (paired blood and synovial fluid from three patients; synovial tissue from two other patients). Clusters coloured red comprise
CD8 cells, clusters coloured blue are CD4 cells. Clusters in grey contain mixed CD4 and CD8 populations. b Heatmap showing memory CD4 and CD8
immune subset signatures. The relative expression of marker genes (columns) across cell clusters (rows) is shown. c–e UMAPs showing the contribution
of PBMC, SFMC and synovial fluid-derived T cells to the integrated UMAP from (a). f–h Volcano plots showing differential expression of genes between
blood and synovial fluid T cells in HLA-DR-low (f), HLA-DR-high (g) and ZNF683+ (h) clusters (Supplementary Data 3a–c). Statistics calculated using
two-sided Wilcoxon Rank Sum test with Bonferroni correction. Genes where adjusted p value <= 1E−04 and average logFC is greater than 0.75 or less
than −0.75 are labelled and shown as red circles. Dotted lines indicate significance and average logFC cut-off for displaying labelled genes (paired blood
and synovial fluid from three patients). Source data are provided as a Source Data file.
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Fig. 3 Clonal expansion of CD8 T cells in psoriatic arthritis. a, b TCR beta-chain V and J-gene usage in PsA blood and synovial fluid generated from 10× 5′
data of patients PSA1505, PSA1607 and PSA1801. V and J segments are represented by arcs, scaled in size to their combined usage by all patients within
each sample type, and giving equal weight to each patient. V–J pairings are represented by ribbons. Plot generated using VDJtools (v1.2.1)36. c UMAP of
PsA synovial fluid CD4 and CD8 T cells from three patients with clonally expanded cells highlighted in red. Clonally expanded cells in synovial fluid
associated most strongly with HLA-DR-high CD8, cycling and ZNF683+ CD8 clusters (odds ratios 12.6, 4.73 and 3.66; adjusted p value 0, 8.7E−19 and
6.1E−64, respectively; two-sided Fisher’s exact test with Bonferroni correction using R stats package; Supplementary Data 7a). d–f Individual clonal
expansion across blood and synovial fluid for three PsA patients based on 10× 5′ data. Circles represent CD8 clonotypes, triangles represent CD4
clonotypes. Data points coloured red show significantly expanded clonotypes (adjusted p value≦ 0.05). Two-sided Fisher’s exact test, Benjamini–Hochberg
correction. g Cluster assignment of enriched CD8 clones in PsA synovial fluid from three patients (PSA1505, PSA1607 and PSA1801). h UMAP plot of
integrated memory T cells from one donor (PSA1607), including cells from 5′ 10× and SS2 datasets (Supplementary Fig. 8). Synovial CD8 T cells from the
clone most enriched in synovial fluid for this patient are highlighted in blue for the 10× data set and red for the SS2 data set. Source data are provided as a
Source Data file.
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with a HLA-DR-low phenotype and one cell with a cycling
phenotype (Supplementary Data 5f). For patient PSA1607, we
combined 10× and Smart-seq 2 gene-expression data to compare
gene expression and clonality across platforms (Supplementary
Fig. 8a–d). We observed cells from the clone maximally enriched
in synovial fluid from each technology within the same clusters
and with a similar magnitude of clonal expansion, validating
our approach (Fig. 3h, Supplementary Fig. 8e, Supplementary
Data 4e, g).
T-cell receptor convergence in PsA synovial clones. To deter-
mine whether clonal expansion of CD8 or CD4 T cells may be
driven by common antigen(s), we used the grouping of lym-
phocyte interactions by paratope hotspots (GLIPH)12 algorithm
to assess TCR complementarity-determining region 3 (CDR3)
similarity and putative shared specificity across all T cells studied
in the 10× experiment (Supplementary Data 6). GLIPH analysis
of 40915 synovial cells with 19582 unique CDR3 beta-chain
amino acid sequences revealed 143 TCR convergence groups
(CRG) with shared specificity between the three patients (Sup-
plementary Data 6a–d). One CRG in particular contained a high
number of cells belonging to synovial-enriched CD8 clones,
including the most enriched clones from two patients (p= 4.2E
−27 and 2.1E−112 for patients PSA1505 and PSA1607, respec-
tively). GLIPH also identified a CDR3 (NQNT) motif in this CRG
(observed vs. expected fold change 10.869, p= 0.001 relative to
the expected frequency in an unselected naive reference TCR
set12). To support these specificity groups, we studied a further
1441 synovial CD4 and CD8 T cells with 1236 unique beta-chain
CDR3 amino acid sequences from three independent patients in
the Smart-seq 2 data set (Supplementary Data 6e, f). GLIPH
analysis incorporating these sequences with the original 10× TCR
sequences obtained from 40,915 cells identified 5 TCR specificity
groups common to all 6 patients (Fig. 4a and Supplementary
Data 6g–j shows the distribution and make-up of the CRGs across
the 6 patients in the two datasets. One of these five groups (CRG-
1) was again assigned the NQNT motif and incorporated the
same clones as the synovial-enriched CRG identified by droplet-
encapsulated data alone (Supplementary Data 6k). CRG-1 con-
tributed the greatest number of expanded clones to the observed
CD8 T-cell expansions in synovial fluid and displayed high usage
of the TCR genes TRBV28 and TRBJ1–1 (Supplementary
data 6g–j, Fig. 4b). Of note, cells from CRG-1 were pre-
dominantly and disproportionately assigned to the ZNF683+ and
HLA-DR- high synovial cell clusters (odds ratios 4.5 and 1.7,
respectively; adjusted p value 3.2E−57 and 4.2E−07, respectively,
Fisher’s exact test with Bonferroni correction (Fig. 4c, d, Sup-
plementary Data 7b)). The HLA-DR-high cluster 5 was defined
by transcripts indicating an activated phenotype, including
granzymes (GZMA, GZMB, GZMH and GZMK), CCL4, CCL5,
CD74 and MHC-II (Fig. 4e, Supplementary Data 3d). ZNF683+
cluster-defining transcripts (Fig. 4f, Supplementary Data 3e)
included KLRC1 (NKG2A), the tissue-residency marker
ZNF68313, the skin/gut-homing marker ITGA1 (CD49a)14 and
granulysin (GNLY). The cells within CRG-1 showed a similar
gene- expression profile compared to their non-CRG-1 neigh-
bours within the same cluster (Supplementary Fig. 9a). Cells from
both the HLA-DR-high and ZNF683+ clusters showed a gene
signature overlapping with previously described tissue-resident
epidermal skin CD49a+ CD8 T cells poised for cytotoxic func-
tion, which were enriched for specific TCR V-gene usage
including TRBV27 and TRBV2815 (Supplementary Fig. 9b).
Chemokine receptor expression and quantification. Compar-
ison of blood and synovial fluid TCR clonotypes showed that
some clonotypes were predominantly enriched in blood, while
others were predominantly enriched in the synovial fluid. To look
for mRNAs that might mediate trafficking, we compared tran-
scriptomes of synovial and blood T cells from clones significantly
enriched in synovial fluid (n= 1766 cells) and blood (n= 842
cells), respectively. Subsetting and reclustering of these 2608 cells
yielded 8 clusters (Fig. 5a, b, Supplementary Data 1e) mapping
back to the original clustering analysis (Fig. 2a). CXCR3 was the
most strongly expressed chemokine receptor gene in synovial-
enriched T-cell clones (avg. logFC= 0.63, adjusted p= 1E−58,
two-sided Wilcoxon rank-sum test with Bonferroni correction),
followed by CXCR6, CCR5 and CCR2, while CX3CR1 (avg. logFC
= 0.66, adjusted p= 4.7E−62) and CXCR5 were more strongly
expressed in peripheral blood-enriched clones (Supplementary
Data 1f). Intercluster variation of chemokine receptor gene
expression within these compartments is visualised in Fig. 5c. The
overexpression of CXCR3 in synovial T cells was striking (avg.
logFC= 0.7, adjusted p= 0, two-sided Wilcoxon rank-sum test
with Bonferroni correction) when mapped back to the whole 10×
5′ data set (Fig. 5d, e, Supplementary Data 1g), and was also
present in synovial cells of the dominant CRG-1 GLIPH CRG
(Supplementary Fig. 9a). To further expand on this finding, we
measured protein levels of IP10 (CXCL10) and CXCL9 (both
ligands for CXCR3), together with MIP1α (CCL3, a ligand for
CCR1, CCR4 and CCR5) and MIP1β (CCL4, a ligand for CCR5),
in the plasma and synovial fluid of patients with PsA (Fig. 5f).
Both CXCR3 ligands were highly enriched in the synovial fluid
compared to blood (p= 0.0004 for CXCL10, p= 0.007 for
CXCL9, paired t test).
Discussion
In this study, we observe striking expansions of memory CD8 and
CD4 T cells in the synovial fluid of patients with large-joint PsA.
The parallel use of complementary single-cell approaches
decreased the chances of bias, in particular through the use of
unsupervised clustering approaches for the CyTOF data, and
followed by validation in a smaller subset of patients using dif-
ferent single-cell mRNA sequencing techniques.
The large number of T cells sequenced from the synovial fluid
and blood of patients with PsA allowed detailed insight into the
cell states found in the joint. Intriguingly, we observe cells in the
synovial fluid, synovial tissue and the peripheral blood that fall
into clusters that have markers of tissue residence and activation.
The existence of these memory phenotypes in the blood is not
surprising, given the exposure of adult human to chronic viral
infections such as EBV and CMV16. When comparing cells falling
within these clusters with their synovial fluid counterparts, we
observe the synovial fluid cells to have increased expression of
cytokines and other markers of effector function including
granzymes.
The use of T-cell receptor VDJ sequencing in this study allows
us to understand the clonal architecture of PsA with a level of
detail not previously possible. We replicate and extend observa-
tions of clonal expansions of CD8 T cells in the joints of patients
with PsA, previously suggested using bulk sequencing techni-
ques4, and now have the ability to track single alpha–beta clones
across the blood and the synovial fluid. Whilst we observe some
hints of clonal expansion in the synovial tissue, the cell numbers
obtained from synovial biopsy in this study prevented us
from studying synovial tissue clonality. Within the synovial fluid,
we here show that almost all expanded CD8 T-cell clones exist in
multiple cell states. Our findings are consistent mechanistically
with previous observations of asymmetric T-cell division17.
The presence of expanded clones expressing markers of activa-
tion, tissue residency and/or tissue homing with evidence of
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shared TCR recognition across patients provides the strongest
evidence yet that PsA is an MHC-I peptide antigen complex-
driven disease and argues against cytokine- or superantigen-
driven expansion. In addition, we also note some CD4 clonal
expansion predominantly in the Treg cluster (Fig. 3c, Fig. 5b,
Supplementary Data 5), suggesting an antigen-driven expansion
of this population in an attempt to regulate the inflammatory
response.
An interesting question posed by this study is the role of tissue-
resident memory T cells in the persistence of inflammation in the
joints. Koebnerization (emergence at sites of trauma) of psoriatic
skin lesions is well recognised18, and large-joint oligo PsA often
recurs in the same joint19. In addition to the description of
ZNF683+ (tissue-resident) CD8 T cells in the skin15, a recent
report replicated the expansion of tissue-resident CD8 T cells in
PsA synovial fluid and showed these cells to have a proin-
flammatory polyfunctional phenotype20. The origin of these
ZNF683+ T cells is intriguing, and the existence of a single clone
in several phenotypic cell states suggests bifurcation in T-cell fate
at some point during proliferation. This phenomenon has pre-
viously been reported in response to infectious challenge21.
Whilst the synovial tissue leucocyte (CD45+) compartment
appears broadly similar to synovial fluid, being mainly composed
of CD3+ T cells and macrophages, subtle differences are
observed. B cells and plasma cells, largely lacking in synovial fluid
samples, account for a considerable proportion of synovial tissue
cells, indicating a potentially differential ability of lymphocytes to
traffic from the tissue to the fluid, or a selective survival advantage
of B-cell lineages in the tissue microenvironment (for which there
is significant evidence in RA22). The presence of B cells is par-
ticularly intriguing since the role of B cells in PsA disease
pathogenesis is unknown with no clear autoantibodies described.
Notably, ectopic lymphoid neogenesis has been described in the
joints in PsA23. The majority of the synovial tissue CD8 cells
associated with a HLA-DR-low cluster phenotype and expressed
fewer activation markers compared to synovial fluid CD8 T cells.
We cannot be sure if differences in disease state may account for
this observation, and larger studies will be needed to understand
these apparent differences in greater detail. Interestingly, HLA-
DR- high and -low CD8 clusters were also reported in a recent
single-cell study of synovial tissue CD8 cells in rheumatoid
arthritis, highlighting potential parallels across these diseases24.
One limitation of our study is that we were unable to obtain
synovial tissue and fluid from the same individuals, which would
have helped elucidate the relationship between tissue and fluid
T cells.
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Our data support a potentially important pathogenic role for
the chemokine receptor CXCR3 in PsA pathogenesis. Increased
CXCR3 gene expression in bulk PsA synovial fluid RNA pre-
parations has been described previously, along with expression of
one of its ligands. Here we show that CXCR3 is highly expressed
on synovial T cells (together with CXCR6, CCR5 and CCR2), and
that both its ligands CXCL9 and CXCL10 are also highly
expressed in the (corresponding) synovial fluids. CXCR3 is
known to be expressed on activated Th1 and CD8 T cells, and
plays a key role in chemotaxis during inflammation25, 26. Inter-
estingly, a reduced number of CXCR3-expressing T cells has
previously been shown in the peripheral blood of patients with
psoriasis, which had been speculated to be due to recruitment of
these cells into skin lesions27. A similar mechanism may operate
in PsA with preferential homing to inflamed joints. In summary,
our findings raise the possibility that CXCR3+ CD8 T cells play a
central role in executing localised inflammation in PsA, and thus
represent an attractive therapeutic target.
A key question raised by this study is the nature of the antigen
or antigens that we propose are driving the clonal expansion of
CD8 T cells in PsA. LL37 has been proposed as an antigen
recognised by CD8 T cells in psoriatic skin, but it will be intri-
guing in follow-up work to understand if common antigens are
recognised in the skin and joint28. In particular, Cheuk and
colleagues showed that TRBV27 was significantly enriched in the
CD49a+ epidermal T-cell compartment of all three donors
sampled in their study15. We believe that the similarities of this
independent study with ours are striking, especially as we also
identify enrichment of TRBV27 in the ZNF683+ population,
which also expresses ITGA1 (CD49a). With application of novel
approaches to identify antigens using MHC/peptide yeast-display
libraries29 or to potentially predict antigens directly from TCR
sequences, these data may in the future allow us to define the
nature of antigens that drive PsA.
Methods
Study participants. Blood and synovial fluid samples were collected with written
informed patient consent from PsA patients undergoing intra-articular aspiration
at Oxford University Hospitals. The study was performed in accordance with
protocols approved by the Oxford Research Ethics committee (Ethics reference
number 06/Q1606/139). Synovial tissue was obtained from knee joints of PsA
patients prior to commencement of any immunomodulatory therapy, including
systemic corticosteroids by a minimally invasive, ultrasound-guided technique with
written informed consent30. Protocols for these procedures were approved by
relevant research ethics committees (reference number 12/NE/0251 Newcastle and
West Midlands Black Country Research Ethics committee 07/H1203/57 (Bir-
mingham)). Upon collection of biopsies, they were immediately cryopreserved in
cryopreservation media Cryostor CS10 (Sigma—MERCK)31. Demographics for all
patients enrolled in this study are listed in Supplementary Table 1.
CyTOF staining and analysis. Whole blood or synovial fluid were fixed with high-
purity paraformaldehyde within 30 min of sample collection. Fixed blood was lysed
with Permeabilization Buffer (eBioscience). Cells were stained in Maxpar staining
buffer (Fluidigm) with antibodies listed in Supplementary Table 2. Samples were
run on a Helios system alongside normalisation beads (Fluidigm). As samples were
run fresh, each paired sample was analysed separately using a custom R work-
flow32, with cell populations clustered using the FlowSOM algorithm version
1.14.08.
Cell isolation for flow cytometry cell-sorting. SFMCs and PBMCs were freshly
isolated within 30 min of sample collection by density-gradient centrifugation
using Histopaque (Sigma). Cells were stained immediately and FACS-sorted for
droplet-based single-cell RNA sequencing. Single-cell suspensions of freshly iso-
lated paired SFMC and PBMC samples from three PsA patients were stained by a
panel of fluorescently conjugated antibodies in staining buffer (RNAse-free PBS, 2
mM EDTA). The following antibodies were used, all from Biolegend: CD3-FITC
(SK7, catalogue number 344803, dilution 1:50), CD4-APC (RPA-T4, catalogue
number 300514, dilution 1:50), CD8a-PE (RPA-T8, catalogue number 301007,
dilution 1:50) and CD45RA-BV421 (HI100, catalogue number 304129, dilution
1:50), together with eFluor780 viability dye (eBioscience, catalogue number 65-
0865-14, dilution 1:250). Memory-enriched (CD45RA -negative) CD3+, CD4+,
CD8− and CD3+ CD8+ CD4− cells were sorted in a 1:1 ratio from both blood
and synovial fluid of patients. Cryopreserved knee synovial tissue biopsies from two
PsA patients were thawed and then digested in digestion buffer cocktail (50ug/ml
LiberaseTM, Sigma and 40ug/ml DNAse I, Roche, in RPMI) in a 37 °C water bath
for 30 min with continuous stirring with a magnetic stir bar in a U-bottom
polystyrene tube (12 × 75 mm2). At 15 min during the digestion, samples were
passed gently 10 times through a 14-G syringe needle for additional mechanical
disruption. After digestion, the cells were filtered using a 70-um filter and washed
prior to staining with antibodies. Following digestion, cells were counted by trypan
blue to assess cell quantity and viability. Cell suspensions were stained with anti-
bodies against CD45-APC (2D1, BD biosciences, catalogue number 340190, dilu-
tion 1:10), and the following antibodies from Biolegend: CD31-PE/Cy7 (WM59,
catalogue number 303117, dilution 1:200), CD326-PE/Cy7 (9C4, catalogue number
324221, dilution 1:50), CD235a-PE/Cy7 (HI264, catalogue number 349111, dilu-
tion 1:20) and CD117-PE/Cy7 (104D2, catalogue number 313211, dilution 1:50).
Cells were also stained with CD3-BUV395 (SK7, BD biosciences, catalogue number
564001, dilution 1:20) to establish post-sorted CD3+ fraction (Supplementary
Fig. 3c). DAPI (Sigma) was added to the stained cells immediately prior to FACS
sorting to isolate live leucocytes prior to loading onto separate channels of the 10×
chromium machine.
Droplet-based single-cell RNA sequencing. For 3′ experiments, freshly isolated
PBMC and SFMC were isolated using density centrifugation, washed and imme-
diately loaded onto chromium controller (10×-Genomics) chip following the
standard protocol for the Chromium single cell 3′ Kit (10× Genomics). For 5′
experiments, sorted memory-enriched CD4 and CD8 T-cell suspensions from
peripheral blood and synovial fluid were prepared. Cells were counted and loaded
into the chromium controller (10×-Genomics) chip following the standard pro-
tocol for the chromium single cell 5′ Kit (10× Genomics). The total time taken
from sample retrieval to sample on the chip was 4 h. A cell concentration was used
to obtain an expected number of captured cells between 5000 and 10,000 cells. All
subsequent steps were done based on the standard manufacturer’s protocol.
Libraries were pooled and sequenced across multiple Illumina HiSeq 4000 lanes to
obtain a read depth of approximately 30,000 reads per cell for gene-expression
libraries and 8500 reads per cell for V(D)J-enriched T-cell libraries.
CD45+ synovial tissue cells were similarly processed using the 10× genomics
chromium controller within 5 h of thawing, then sequenced using the NovaSeq
sequencer and S2 flowcell to a read depth of over 1,000,000 reads per cell to achieve
an estimated sequencing saturation of over 97% for both samples. Mean-used read
pairs per cell for V(D)J libraries were over 35,000 for both samples.
Plate-based single-cell RNA sequencing. Freshly sorted CD45RA-negative
CD3+CD4+, and CD3+CD8+ single cells from four patients were individually
flow-sorted into 96-well full-skirted plates (Eppendorf) containing 10 µL of 2%
Dithiothreitol (DTT, 2 M Sigma-Aldrich), RTL lysis buffer (Qiagen) solution. Cell
lysates were sealed, mixed and spun down before storing at −80 °C. Paired-end
multiplexed sequencing libraries were prepared following the Smart-seq 2 (SS2)
protocol33 using the Nextera XT DNA library prep kit (Illumina). A pool of bar-
coded libraries from four different plates were sequenced across two lanes on the
Illumina HiSeq 2500.
Droplet-based single-cell RNA-seq mapping and pre-processing. The raw
single-cell sequencing data were mapped and quantified using the 10× Genomics
Inc. software package CellRanger (v2.1 for peripheral blood and synovial fluid
samples and v3.0.2 for synovial tissue samples) against the GRCh38-1.2.0 reference
provided by 10×. Using the table of unique molecular identifiers produced by
CellRanger, we identified droplets that contained cells using the call of functional
droplets generated by CellRanger.
Quality control of droplet-based single-cell data. After cell-containing droplets
were identified, gene-expression matrices of synovial fluid and peripheral blood-
derived cells were first filtered to remove cells with >10% mitochondrial genes,
<500 or >3500 genes and >25,000 UMI. Cells were further filtered to exclude
multiplets defined as cells with greater than 1 beta chain or greater than 2 alpha
chains where TCR sequencing data were available, and cells having both CD4 and
CD8 gene expression where cells were sorted as either CD8+ or CD4+ by FACS.
Matrices of synovial tissue-derived cells were similarly filtered to exclude cells with
>10% mitochondrial genes, <200 or >2000 genes and >10,000 UMI. No multiplets
were identified in synovial tissue sample data based on available TCR sequences.
QC of SS2-based single-cell expression data. Cells with more than 5 median
absolute deviations (MAD) 8.35% of their mRNA originating from mitochondrial
genes, a total number of reads <500,000 or >5,000,000, a total number of counts >3
MAD or with the number of genes <1000 or >6000, were filtered out prior to
downstream analysis. Where matching TCR data for a cell was available, any cells
with greater than 1 beta chain or greater than 2 alpha chains were additionally
filtered.
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3′ analysis of peripheral blood and synovial fluid. Sequencing reads from six
datasets (three PBMC, three SFMC) were mapped with CellRanger V2.1.0
GRCh38 (ENSEMBL annotation). Quality control, filtering and clustering
analysis was carried out with the R package Seurat version 3.0.0. To exclude
low-quality cells, cells with fewer than 500 genes were excluded. Likely doublets
were removed by filtering out cells with greater than 2500 genes or 10,000
UMIs. All cells with a mitochondrial fraction greater than 5% were also
excluded. In total, 8606 PBMC cells and 7221 SFMC cells passed the filtering.
The 6 datasets were SCT-transformed and then merged using the top 3000
variable genes. The RunPCA function was used to calculate 30 principal com-
ponents, and SNN graph constructed using 30 dimensions and the SCT assay.
Clustering was then performed on the SNN of the merged SCT assay at a
resolution of 0.8 with otherwise default parameters, which yielded a total of 15
clusters classified by differentially expressed genes (Supplementary Fig. 2a) and
visualised by UMAP.
5′ integration of peripheral blood, synovial fluid and tissue. Cellranger 5′ 10×
output included eight expression matrices derived from the paired blood and
synovial fluid T-cell-sorted (Supplementary Fig. 3) samples of three PsA patients,
and synovial tissue leukocyte samples from two additional PsA patients. Down-
stream analyses of these matrices were carried out using R (version 3.6.1) primarily
utilising the Seurat package (v3.1.4, satijalab.org/seurat).
CD45+ synovial tissue samples were first analysed as a whole. QC-filtered
matrices from both patients were individually normalised using the
SCTransform algorithm (min_cells= 1, return.only.var.genes= F) before
merging into a single SCTransform-based (SCT) assay and determining the top
2000 variable genes, excluding TCR and BCR genes, of that assay. The
Shared Nearest Neighbour (SNN) graph was then calculated using 30
dimensions, and 9 clusters were identified at a resolution of 1.3 according to the
standard Seurat workflow (Supplementary Fig. 4). Cells belonging to T-cell
clusters 2, 3 and 8 from this analysis and found to express at least 1 RNA
transcript of CD3E were identified for downstream analysis as synovial tissue
T cells.
To compare T cells across all sample types, QC-filtered blood and synovial fluid
matrices were subsampled to include an equal number of cells for all patients (6867
cells per sample, totalling 41,202 cells) and analysed together with previously
identified QC-filtered synovial tissue T cells of two patients. All eight datasets were
individually normalised using the SCTransform function (min_cells= 1, return.
only.var.genes= F). The eight datasets were then merged, and the top 2000 variable
genes, excluding TCR and BCR genes, were identified from the SCT assay. The
RunPCA function was used to calculate 30 principal components, and SNN graph
constructed using 30 dimensions and the SCT assay. Clustering was then
performed on the SNN of the merged SCT assay at a resolution of 0.65 with
otherwise default parameters, which yielded a total of 16 clusters classified by
differentially expressed genes (Supplementary Fig. 5) and visualised by UMAP
(Fig. 2a).
For a focused analysis of clones enriched in either peripheral blood or synovial
fluid, the six QC- filtered, SCTransformed datasets of T cells from both sample
types were merged, and all cells corresponding to clones enriched in either sample
type subsetted. Only cells belonging to the same sample type in which the clone was
enriched were considered. The resulting clonally enriched subset consisted of
1766 synovial fluid and 842 peripheral blood T cells. The top 2000 variable genes
excluding TCR genes were calculated from the SCT assay of this enriched subset,
and 75 principal components calculated using the RunPCA function before
constructing a SNN graph based on 75 dimensions and the SCT assay. Clustering
was then performed on the SNN of the merged SCT assay at a resolution of 0.5
with otherwise default parameters, which yielded a total of eight clusters classified
by differentially expressed genes (Supplementary Data 1e) and visualised by UMAP
split across both sample types (Fig. 5a, b).
Droplet- and SS2-based integration. For validation of sequencing data across
platforms, QC-filtered 10× expression matrices from one patient (PSA1607)
were subsampled to include an equal number of T cells from blood and synovial
fluid (12,200 cells from each, totalling 24,400 cells). QC-filtered SS2 data
matrices from this same patient were similarly subsampled to include 433
T cells from both blood and synovial fluid. As all samples were from the same
patient and of the same sorted cell type, an integration approach was adopted
that utilised the larger 10× samples as a reference to project clustering onto the
smaller number of SS2 cells.
In all, 10× and SS2 datasets were first individually normalised using the
SCTransform function. Integration features, excluding TCR genes, were then
calculated using the Seurat SelectIntegrationFeatures function and passed as an
argument to the FindIntegrationAnchors function run with an SCT normalisation
method and 10× datasets as reference. The Seurat IntegrateData function was
finally used to integrate all sample datasets from the two single-cell sequencing
platforms based again on the SCT normalisation method. The normal Seurat
pipeline was then followed, calculating 50 principal components and constructing a
SNN graph using 50 dimensions and the integrated assay. Clustering was
performed on the integrated assay at a resolution of 0.65 with otherwise default
parameters, which yielded a total of 15 clusters classified by differentially expressed
genes (Supplementary Data 1d) and visualised by UMAP (Supplementary Fig. 8).
TCR mapping. Chromium 10× V(D)J single-cell sequencing data were mapped
and quantified using the software package CellRanger (v2.1 for peripheral blood
and synovial fluid samples and v3.0.1 for synovial tissue samples) against the
GRCh38 reference provided by 10× Genomics with that release. The generated
consensus annotation files for each patient and sample type (blood or synovial
fluid) were then used to construct clonality tables and input files for further
downstream analysis. Full-length, paired TCR nucleotide sequences from SS2 data
were constructed using the TraCeR program34, and further mapped to V, D and J
genes as well as CDR3 nucleotide and amino acid sequences using the online
IMGT-HighVQuest tool (v3.4.13)35. The software package GLIPH v1.0 was used to
construct and assess specificity groups12. As the GLIPH algorithm only makes use
of single-CDR3 beta-chain amino acid sequences to associate clones of common
specificity, multiple beta-chain sequences within the same partition were treated as
multiplets and provided as separate individual sequences to GLIPH (annotated
with a v suffix). Partitions containing only alpha-chain sequences were excluded
from GLIPH input. The VDJtools 1.1.836 software package was used to construct
circle plots illustrating V(D)J-gene usage.
To assess clonal enrichment, the proportion of cells having the same clone was
compared between sample types for each clone using a two-sided Fisher’s exact test
with Benjamini and Hochberg (1995) correction for multiple comparisons (R Stats
Package). A cell’s clonotype was defined as the combined alpha- and beta-chain
CDR3 nucleotide sequences for that cell. As it was not possible to deduce beta- and
alpha-chain pairing for partitions with multiple beta chains, these partitions were
treated as a single clone. When analysing both gene expression and clonality of the
same cells, partitions containing more than one beta chain or more than two alpha
chains were excluded from analysis as multiplets.
Plate-based single-cell RNA-sequencing expression. To assess the expression
from the SS2 data, raw reads were pseudo-mapped and counted using kallisto
v0.43.137 based on the annotation made by ENSEMBL(v90) of the human reference
genome (GRCh38). To obtain per-gene counts, all of the transcript counts were
summarised using scater v1.6.338.
Chemokine protein quantification. Paired plasma and synovial fluid supernatant
was collected from patients undergoing knee aspiration procedures and frozen at
−80 °C within 1 h of sample collections. Samples were thawed, and chemokine
protein quantification was performed using a LEGENDplex™ Human Proin-
flammatory Chemokine Panel (13-plex) immunoassay (Cat# 740003) according to
the manufacturer’s instructions. Samples were acquired on two different dates, with
similar results obtained. The data were acquired on a Novocyte instrument and
analysed using the LEGENDplex™ Data Analysis Software (v8.0) provided by
BioLegend.
Data visualisation. UMAP plots were generated using umap-learn (0.3.10) exe-
cuted within a Python (3.6.10), numpy (version 1.18.1) environment.
Statistical analyses. Statistical tests were performed as indicated in the figure
legends.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The datasets generated and/or analysed during the current study are available from the
corresponding author on reasonable request. Sequencing data that support the findings
of this study have been deposited in ArrayExpress with the accession code E-MTAB-9492
and in the European Genome-phenome Archive (EGA) with accession code
EGAS00001002104. Source data are provided with this paper.
Code availability
All code used to analyse data and synthesise the figures is available on request from the
authors.
Received: 6 August 2019; Accepted: 27 August 2020;
References
1. Ibrahim, G., Waxman, R. & Helliwell, P. S. The prevalence of psoriatic
arthritis in people with psoriasis. Arthritis Rheum. 61, 1373–1378 (2009).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18513-6
10 NATURE COMMUNICATIONS |         (2020) 11:4767 | https://doi.org/10.1038/s41467-020-18513-6 | www.nature.com/naturecommunications
2. Veale, D. J. & Fearon, U. The pathogenesis of psoriatic arthritis. Lancet 391,
2273–2284 (2018).
3. Stuart, P. E. et al. Genome-wide association analysis of psoriatic arthritis and
cutaneous psoriasis reveals differences in their genetic architecture. Am. J.
Hum. Genet. 97, 816–836 (2015).
4. Costello, P. J. et al. Psoriatic arthritis joint fluids are characterized by CD8 and
CD4 T cell clonal expansions that appear antigen driven. J. Immunol. 166,
2878–2886 (2001).
5. May, E. et al. Conserved TCR beta chain usage in reactive arthritis; evidence
for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens
60, 299–308 (2002).
6. Muntyanu, A. et al. Differential gene and protein expression of chemokines
and cytokines in synovial fluid of patients with arthritis. Arthritis Res. Ther.
18, 296 (2016).
7. Moll, J. M. H. & Wright, V. Psoriatic arthritis. Semin. Arthritis Rheum. 3,
55–78 (1973).
8. Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization
and interpretation of cytometry data. Cytometry A 87, 636–645 (2015).
9. Walker, L. J. et al. Human MAIT and CD8αα cells develop from a pool of
type-17 precommitted CD8+ T cells. Blood 119, 422–433 (2012).
10. Ellinghaus, E. et al. Genome-wide meta-analysis of psoriatic arthritis identifies
susceptibility locus at REL. J. Investig. Dermatol. 132, 1133–1140 (2012).
11. Rubin, C. I. & Atweh, G. F. The role of stathmin in the regulation of the cell
cycle. J. Cell. Biochem. 93, 242–250 (2004).
12. Glanville, J. et al. Identifying specificity groups in the T cell receptor
repertoire. Nature 547, 94–98 (2017).
13. Mackay, L. K. et al. Hobit and Blimp1 instruct a universal transcriptional
program of tissue residency in lymphocytes. Science 352, 459–463 (2016).
14. Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core
transcriptional and functional signatures in lymphoid and mucosal sites. Cell
Rep. 20, 2921–2934 (2017).
15. Cheuk, S. et al. CD49a expression defines tissue-resident CD8+ T cells poised
for cytotoxic function in human skin. Immunity 46, 287–300 (2017).
16. Khan, N. et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire
toward greater clonality in healthy elderly individuals. J. Immunol. 169,
1984–1992 (2002).
17. Flossdorf, M., Rössler, J., Buchholz, V. R., Busch, D. H. & Höfer, T. CD8 + T cell
diversification by asymmetric cell division. Nat. Immunol. 16, 891–893 (2015).
18. Chen, L. & Shen, Z. Tissue-resident memory T cells and their biological
characteristics in the recurrence of inflammatory skin disorders. Cell. Mol.
Immunol. 17, 64–75 (2020).
19. Tinazzi, I. et al. ‘Deep Koebner’ phenomenon of the flexor tendon-associated
accessory pulleys as a novel factor in tenosynovitis and dactylitis in psoriatic
arthritis. Ann. Rheum. Dis. 77, 922–925 (2018).
20. Steel, K. J. A. et al. Polyfunctional, proinflammatory, tissue-resident memory
phenotype and function of synovial interleukin-17A+CD8+ T cells in
psoriatic arthritis. Arthritis Rheumatol. 72, 435–447 (2020).
21. Lönnberg, T. et al. Single-cell RNA-seq and computational analysis using
temporal mixture modeling resolves TH1/TFH fate bifurcation in malaria. Sci.
Immunol. 2, eaal2192 (2017).
22. Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives
B cells in rheumatoid arthritis. Nature 542, 110–114 (2017).
23. Cañete, J. D. et al. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann.
Rheum. Dis. 66, 720–726 (2007).
24. Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint
synovial tissues by integrating single-cell transcriptomics and mass cytometry.
Nat. Immunol. 20, 928 (2019).
25. Smit, M. J. et al. CXCR3-mediated chemotaxis of human T cells is regulated by
a Gi- and phospholipase C–dependent pathway and not via activation of
MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood 102, 1959–1965 (2003).
26. Kurachi, M. et al. Chemokine receptor CXCR3 facilitates CD8+ T cell
differentiation into short-lived effector cells leading to memory degeneration.
J. Exp. Med. 208, 1605–1620 (2011).
27. Lima, X. T. et al. Circulating levels of chemokines in psoriasis. Autoimmunity
48, 57–60 (2015).
28. Lande, R. et al. The antimicrobial peptide LL37 is a T-cell autoantigen in
psoriasis. Nat. Commun. 5, 1–16 (2014).
29. Birnbaum, M. E. et al. Deconstructing the peptide-MHC specificity of T cell
recognition. Cell 157, 1073–1087 (2014).
30. Humby, F. et al. A multicenter retrospective analysis evaluating performance
of synovial biopsy techniques in patients with inflammatory arthritis:
arthroscopic versus ultrasound-guided versus blind needle biopsy. Arthritis
Rheumatol. 70, 702–710 (2018).
31. Donlin, L. T. et al. Methods for high-dimensional analysis of cells
dissociated from cryopreserved synovial tissue. Arthritis Res. Ther. 20, 139
(2018).
32. Nowicka, M. et al. CyTOF workflow: differential discovery in high-throughput
high-dimensional cytometry datasets. F1000Research 6, 748 (2017).
33. Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat.
Protoc. https://doi.org/10.1038/nprot.2014.006 (2014).
34. Stubbington, M. J. T. et al. T cell fate and clonality inference from single-cell
transcriptomes. Nat. Methods 13, 329–332 (2016).
35. Aouinti, S., Malouche, D., Giudicelli, V., Kossida, S. & Lefranc, M.-P. IMGT/
highV-QUEST statistical significance of IMGT clonotype (AA) diversity per gene
for standardized comparisons of next generation sequencing immunoprofiles of
immunoglobulins and T cell receptors. PLoS ONE 10, e0142353 (2015).
36. Shugay, M. et al. VDJtools: unifying post-analysis of T cell receptor
repertoires. PLOS Comput. Biol. 11, e1004503 (2015).
37. Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic
RNA-seq quantification. Nat. Biotechnol. 34, 525–527 (2016).
38. McCarthy, D. J., Campbell, K. R., Lun, A. T. L. & Wills, Q. F. Scater: pre-
processing, quality control, normalization and visualization of single-cell
RNA-seq data in R. Bioinformatics 33, btw777 (2017).
Acknowledgements
We thank Jon Webber and Catherine Simpson for assistance with the cell sorting. We are
grateful to Muzlifah Haniffa for critical review of the paper. The research was funded by
The Kennedy Trust Studentship (F.P.), The Academy of Medical Sciences Grant to H.A.
(SGL018\1006) and Personal fellowship support H.A. (Oxford-UCB Prize fellowship)
S.B. (Wellcome, St. Baldrick’s Foundation), C.B. (Wellcome). P.B. and H.A. are funded
by the National Institute for Health Research (NIHR) Oxford Biomedical Research
Centre (BRC); A.F. is funded by the NIHR Birmingham BRC at the University Hospitals
Birmingham NHS Foundation Trust and the University of Birmingham. Work in the JDI
laboratory is supported by the National Institute of Health Research (NIHR) Newcastle
Biomedical Research Centre at Newcastle Hospitals Foundation Trust and Newcastle
University and Versus Arthritis Research into Inflammatory Arthritis Centre, ref. 22072.
The views expressed are those of the author(s) and not necessarily those of the NHS, the
NIHR or the Department of Health.
Author contributions
H.A.-M. and S.B. conceived and designed the experiments; F.P., L.N.N. and H.A.-M.
performed the 10× experiments, designed and performed the computational analysis
aided by M.D.C.V.H., M.D.Y., L.M., M.E. and D.S.; M.D.C.V.H. performed the SMART-
seq 2 experiments assisted by C.G. and L.M.; N.Y. performed the CyTOF experiments
assisted by A.L.L., S.C. and A.M.; N.Y., A.L.L. and S.C. performed the flow cytometry and
assisted with the cell sorting; A.L.C. performed the protein quantification assays; A.G.P.,
K.R. and A.F. curated the pretreatment early arthritis cohorts and performed synovial
biopsies; L.N.N. performed the synovial tissue processing; S.T., J.D.I. and C.B. con-
tributed to the discussions; H.A.-M., S.B. and P.B. wrote the paper; P.B., S.B. and H.A.-M.
co-directed this study. All authors read and approved the paper.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41467-
020-18513-6.
Correspondence and requests for materials should be addressed to S.B. or M.H.A.-M.
Peer review information Nature Communications thanks Evan Newell and the other,
anonymous, reviewer(s) for their contribution to the peer review of this work. Peer
reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribu-
tion 4.0 International License, which permits use, sharing, adaptation,
distribution and reproduction in any medium or format, as long as you give appropriate
credit to the original author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise in a
credit line to the material. If material is not included in the article’s Creative Commons
license and your intended use is not permitted by statutory regulation or exceeds the
permitted use, you will need to obtain permission directly from the copyright holder. To
view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2020
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18513-6 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:4767 | https://doi.org/10.1038/s41467-020-18513-6 | www.nature.com/naturecommunications 11
